Article Details

Weight-Based Dosing With Narsoplimab Is Recommended in HSCT-TMA

Retrieved on: 2021-04-07 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

Weight-Based Dosing With Narsoplimab Is Recommended in HSCT-TMA. View article details on hiswai:

Excerpt

The endothelial injury occurs after the lectin pathway of complement is activated. Narsoplimab, a fully human IgG4 monoclonal antibody, inhibits MASP- ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up